Spinocerebellar Ataxia Type 3 Latest Advances
Find the Latest Research About Spinocerebellar Ataxia Type 3
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1468 publications
Twice-Daily Scrambler Therapy for a Patient With Spinocerebellar Ataxia Suffering From Refractory Neuropathic Back Pain: A Case Report.
Journal: Cureus
Published: May 04, 2026
Retrotransposition Events Shape the Evolution of the Ataxin-3 Gene Family in Primates.
Journal: Genome biology and evolution
Published: February 20, 2026
Response to the Letter by Dr. Zarrouk et al.
Journal: Internal medicine (Tokyo, Japan)
Published: February 11, 2026
SCA3 Can Manifest Phenotypically with ALS-like Characteristics.
Journal: Internal medicine (Tokyo, Japan)
Published: February 11, 2026
Somatosensory Evoked Potentials in Spinocerebellar Ataxia Type 3 and Type 10.
Journal: Cerebellum (London, England)
Published: February 09, 2026
Stage-Dependent Dyslipidemia in Spinocerebellar Ataxia Type 3 Masked by Disease-Associated Low Body Mass Index.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: February 08, 2026
Intermittent Theta-Burst Stimulation (iTBS) Improves Motor Coordination and Modulates Neuroinflammation and Autophagy in SCA3/MJD Mice.
Journal: Cerebellum (London, England)
Published: February 05, 2026
Corticospinal tract involvement in Spinocerebellar ataxias type 1, 2 and 3 characterized by motor evoked potentials and diffusion MRI.
Journal: Parkinsonism & related disorders
Published: February 02, 2026
JOSD2 deubiquitinating enzyme: Structure, function, and potential as a therapeutic target.
Journal: Cellular signalling
Published: January 23, 2026
Nongenetic Factors Associated with Age at Onset and Disease Severity in Spinocerebellar Ataxia Type 3: A Cross-Sectional Cohort Study.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: January 07, 2026
Last Updated: 06/30/2026